Specifically, the overexpression of MAN2B1 in glioma tissues is associated with immune response and anti-inflammatory functions by correlating with the expression of tumor-associated macrophages and M2 macrophages, and correlates with malignant clinical features and poor outcome for glioma patients (96). This evidence concerns the gene MAN2B1 and central nervous system cancer.